NCT07433673
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07433673
Title Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) (GAP Cemi)
Acronym GAP Cemi
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Columbia University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.